Ингибирование белка S6K1, или его отсутствие, замедляет производство жировых клеток, нарушая и замедляя начальную стадию их образования. Исследование может иметь значение для лечения ожирения.[3]
Другой путь, в котором участвует P70, мышечное удлинение и рост. P70 фосфорилируется пассивно при напряжении камбаловидной мышцы. Она может быть одной из многих протеинкиназ, участвующих в мышечной ткани.[4]
↑ Van Dyke JM, Bain JL, Riley DA (April 2013). “Stretch activated signaling is modulated by stretch magnitude and contraction”. Muscle Nerve. 49 (1): 98—107. DOI:10.1002/mus.23880. PMID23620271.
↑ Nemazanyy I, Panasyuk G, Zhyvoloup A, Panayotou G, Gout IT, Filonenko V (2004). “Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism”. FEBS Lett. 578 (3): 357—62. DOI:10.1016/j.febslet.2004.10.091. PMID15589845.
↑ Panasyuk G, Nemazanyy I, Zhyvoloup A, Bretner M, Litchfield DW, Filonenko V, Gout IT (2006). “Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17”. J. Biol. Chem. 281 (42): 31188—201. DOI:10.1074/jbc.M602618200. PMID16895915.
↑ Holz MK, Ballif BA, Gygi SP, Blenis J (2005). “mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events”. Cell. 123 (4): 569—80. DOI:10.1016/j.cell.2005.10.024. PMID16286006.
↑ Ali SM, Sabatini DM (2005). “Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site”. J. Biol. Chem. 280 (20): 19445—8. DOI:10.1074/jbc.C500125200. PMID15809305.
↑ Ha SH, Kim DH, Kim IS, Kim JH, Lee MN, Lee HJ, Kim JH, Jang SK, Suh PG, Ryu SH (2006). “PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals”. Cell. Signal. 18 (12): 2283—91. DOI:10.1016/j.cellsig.2006.05.021. PMID16837165.
↑ Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K (2002). “Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action”. Cell. 110 (2): 177—89. DOI:10.1016/S0092-8674(02)00833-4. PMID12150926.
↑ Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, Yoshino K, Hara K, Tanaka N, Avruch J, Yonezawa K (2003). “The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif”. J. Biol. Chem. 278 (18): 15461—4. DOI:10.1074/jbc.C200665200. PMID12604610.
↑ Chiang GG, Abraham RT (2005). “Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase”. J. Biol. Chem. 280 (27): 25485—90. DOI:10.1074/jbc.M501707200. PMID15899889.
↑ Holz MK, Blenis J (2005). “Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase”. J. Biol. Chem. 280 (28): 26089—93. DOI:10.1074/jbc.M504045200. PMID15905173.
↑ Isotani S, Hara K, Tokunaga C, Inoue H, Avruch J, Yonezawa K (1999). “Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro”. J. Biol. Chem. 274 (48): 34493—8. DOI:10.1074/jbc.274.48.34493. PMID10567431.
↑ Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005). “Rheb binds and regulates the mTOR kinase”. Curr. Biol. 15 (8): 702—13. DOI:10.1016/j.cub.2005.02.053. PMID15854902.
↑ Toral-Barza L, Zhang WG, Lamison C, Larocque J, Gibbons J, Yu K (2005). “Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay”. Biochem. Biophys. Res. Commun. 332 (1): 304—10. DOI:10.1016/j.bbrc.2005.04.117. PMID15896331.
↑ Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G (2002). “Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site”. J. Biol. Chem. 277 (22): 20104—12. DOI:10.1074/jbc.M201745200. PMID11914378.
↑ Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2002). “mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery”. Cell. 110 (2): 163—75. DOI:10.1016/S0092-8674(02)00808-5. PMID12150925.
↑ Edinger AL, Linardic CM, Chiang GG, Thompson CB, Abraham RT (2003). “Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells”. Cancer Res. 63 (23): 8451—60. PMID14679009.
↑ Leone M, Crowell KJ, Chen J, Jung D, Chiang GG, Sareth S, Abraham RT, Pellecchia M (2006). “The FRB domain of mTOR: NMR solution structure and inhibitor design”. Biochemistry. 45 (34): 10294—302. DOI:10.1021/bi060976+. PMID16922504.
↑ Takahashi T, Hara K, Inoue H, Kawa Y, Tokunaga C, Hidayat S, Yoshino K, Kuroda Y, Yonezawa K (2000). “Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro”. Genes Cells. 5 (9): 765—75. DOI:10.1046/j.1365-2443.2000.00365.x. PMID10971657.
↑ Bishop JD, Nien WL, Dauphinee SM, Too CK (2006). “Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells”. J. Endocrinol. 190 (2): 307—12. DOI:10.1677/joe.1.06368. PMID16899564.
1 2 Panasyuk G, Nemazanyy I, Filonenko V, Gout I (2008). “Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1”. Biochem. Biophys. Res. Commun. 369 (2): 339—43. DOI:10.1016/j.bbrc.2008.02.016. PMID18279656.
Данная страница на сайте WikiSort.ru содержит текст со страницы сайта "Википедия".
Другой контент может иметь иную лицензию. Перед использованием материалов сайта WikiSort.ru внимательно изучите правила лицензирования конкретных элементов наполнения сайта.
2019-2025 WikiSort.ru - проект по пересортировке и дополнению контента Википедии